The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R03 | Drugs for obstructive airway diseases | |
| 3 | R03C | Adrenergics for systemic use | |
| 4 | R03CB | Non-selective beta-adrenoreceptor agonists |
| Code | Title | |
|---|---|---|
| R03CB01 | Isoprenaline | |
| R03CB02 | Methoxyphenamine | |
| R03CB03 | Orciprenaline | |
| R03CB51 | Isoprenaline, combinations | |
| R03CB53 | Orciprenaline, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Isoprenaline |
Isoprenaline is a potent non selective beta-adrenergic agonist with low affinity for alphaadrenergic receptors. Isoprenaline acts primarily on the heart and on smooth muscle of bronchi, skeletal muscle vasculature and the gastrointestinal tract. |
|
| Methoxyphenamine |
Methoxyphenamine is a beta adrenergic receptor agonist nd is used as a bronchodilator to treat asthma, chronic obstructive pulmonary disease (COPD) and postinfectious cough. |
|
| Metaproterenol |
Orciprenaline sulphate is a bronchodilating agent. The bronchospasm associated with various pulmonary diseases-chronic bronchitis, pulmonary emphysema, bronchial asthma, silicosis, tuberculosis, sarcoidosis and carcinoma of the lung, has been successfully reversed by therapy with orciprenaline sulphate. |
